VATC Antibody Blocking peptide
VATC Antibody Blocking peptide
Product Specifications
Product Name Alternative
V-type proton ATPase subunit C 1, V-ATPase subunit C 1, Vacuolar proton pump subunit C 1, ATP6V1C1, ATP6C, ATP6D, VATC
UniProt
P21283
Field of Research
Neuroscience
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Center region of human VATC. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL310913V 500 µL Each
OR2G2 Human shRNA Lentiviral Particle (Locus ID 81470)
Sign In for Pricing
View Details 
MBS1222691-01 0.02 mg (E-Coli)
Recombinant Cyanidioschyzon merolae Protein cfxQ homolog (cfxQ)
Sign In for Pricing
View Details MBS1222691-02 0.02 mg (Yeast)
Recombinant Cyanidioschyzon merolae Protein cfxQ homolog (cfxQ)
Sign In for Pricing
View Details MBS1222691-03 0.1 mg (E-Coli)
Recombinant Cyanidioschyzon merolae Protein cfxQ homolog (cfxQ)
Sign In for Pricing
View Details MBS1222691-04 0.1 mg (Yeast)
Recombinant Cyanidioschyzon merolae Protein cfxQ homolog (cfxQ)
Sign In for Pricing
View Details